Andy Intlekofer

Physician scientist in HOPP and DOM/Lymphoma at Memorial Sloan Kettering. Our lab studies the metabolic control of cell fate and oncogenesis. Tweets are my own.

[Andy Intlekofer @IntlekoferLab]

It was an honor to be part of this team effort to understand how some cancers develop resistance to IDH inhibitors. Thank you Alan Shih, Eytan Stein, Craig Thompson, and Ross Levine! ⁦@rosslevinemd⁩ @sloan_kettering⁩ #mskcc https://t.co/A4i6CDsWDt

[Abdel-Wahab Lab @AbdelWahablab]

Excited to share our collaboration w/ @bradleybio demonstrating that pharmacologic modulation of splicing induces immunogenic neoantigens and augments response to checkpoint blockade. Jointly led by @SXLuLab, @ejdeneef, @jdthomaslab. Out today in @Cell:
https://t.co/kKWVNjnv9C

[Santosh Vardhana @SantoshVardhana]

So proud that the first paper from @VardhanaLab, an equal collaboration with @Ron_cology and Alex Huang's lab, is out today in @NatureMedicine: https://t.co/kQGH0haNZO. I posted a long tweetorial about this study when it was a preprint, but a few additional thoughts:

[Kentsis Research Group @KentsisResearch]

Please read and use our latest work with @CompProteomics on agnostic chemical proteomics: Discovery of Protein Modifications Using Differential Tandem Mass Spectrometry Proteomics https://t.co/lopuRB2NVI

[Andy Intlekofer @IntlekoferLab]

@Caroline_Bartma Same problem here 😭

[Andy Intlekofer @IntlekoferLab]

@S__Baksh Please stay forever 🤩

[Andy Intlekofer @IntlekoferLab]

@S__Baksh You kids these days and your short theses...

[Andy Intlekofer @IntlekoferLab]

@acarrer Hi @acarrer. I can also send you my slide decks!

[Andy Intlekofer @IntlekoferLab]

@TennessenLab Congrats Jason! Very cool stuff as always!

[Andy Intlekofer @IntlekoferLab]

@ScaltritiLab @MSKHemOncTrials @sloan_kettering We will miss you! Stay in touch!

[Mary Baylies @BayliesLab]

Congrats to @SylviaZohrabian and @IntlekoferLab ! @WeillCornellGS and #WCGSBCMB directors are so pleased ! Yay! Keep the good news coming!

[Andy Intlekofer @IntlekoferLab]

Congratulations to my very first graduate student ⁦@SylviaZohrabian⁩ for receiving the ⁦@DeptofDefense Horizon Award! A welcome piece of good news in a difficult year. ⁦@WeillCornellGS⁩ ⁦@sloan_kettering⁩. Meet Our 2021 Fellows... https://t.co/96KzRJtbv1

[Memorial Sloan Kettering Cancer Center @MSKCancerCenter]

#CancerCare can’t wait. If you or someone you know has symptoms or has been diagnosed with cancer, please don’t wait. The #cancer experts at Memorial Sloan Kettering are here for you. Connect with an MSK cancer expert. https://t.co/PKGFgwD3Xi #MSKAlways

[Andy Intlekofer @IntlekoferLab]

For all aspiring cancer researchers, check out the PhD program @GSKGradSchool @sloan_kettering. It’s an amazing and supportive environment to train in!

[GSK Graduate School @GSKGradSchool]

Learn more about our #PhD program in #Cancer #Biology and #BiomedicalSciences by joining a virtual information session. Hear from our Deans and students about the innovative program embedded within @sloan_kettering in #NYC. Register on our webpage

https://t.co/PWCmDEIQwh

[GSK Graduate School @GSKGradSchool]

Learn more about our #PhD program in #Cancer #Biology and #BiomedicalSciences by joining a virtual information session. Hear from our Deans and students about the innovative program embedded within @sloan_kettering in #NYC. Register on our webpage

https://t.co/PWCmDEIQwh

[Andy Intlekofer @IntlekoferLab]

@Jessica_Okosun @AACR @EfeyanLab Thanks @Jessica_Okosun - excited to hear your talk on Wednesday!

[Nature Reviews Cancer @NatureRevCancer]

New Review online! T Nielsen &co discuss how the disease biology of many sarcomas is driven by #chromatin pathway alterations w/ a view to use this knowledge to better develop targeted therapies for patients with #sarcoma.

https://t.co/nSf5BM360k

@NatResCancer #DNAmethylation